Clinical Pharmacogenomics | List of Frontiers open access articles

Mini Review

Published on 05 Apr 2019

Integrating Next-Generation Sequencing in the Clinical Pharmacogenomics Workflow

in Pharmacogenetics and Pharmacogenomics

Efstathia Giannopoulou
Theodora Katsila
Christina Mitropoulou
Evangelia-Eirini Tsermpini
George P. Patrinos

Frontiers in Pharmacology

doi 10.3389/fphar.2019.00384

12,312 views
37 citations

Original Research

Published on 09 May 2024

Assessing user perspectives on clinical pharmacogenomics consultation documentation: a user-centered evaluation

in Pharmacogenetics and Pharmacogenomics

Nina Desai
Namratha Ravindra
Bradley Hall
Hana Al Alshaykh
Lauren Lemke
Eda Eken
Emily J. Cicali
Kristin Wiisanen
Larisa H. Cavallari
Khoa A. Nguyen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1377132

2,365 views

Review

Published on 21 May 2019

Pharmacogenetic Factors Affecting Asthma Treatment Response. Potential Implications for Drug Therapy

in Pharmacogenetics and Pharmacogenomics

Jesús Miguel García-Menaya
Concepción Cordobés-Durán
Elena García-Martín
José A. G. Agúndez

Frontiers in Pharmacology

doi 10.3389/fphar.2019.00520

16,061 views
48 citations

Brief Research Report

Published on 09 Sep 2025

Comparative evaluation of Oxford Nanopore Technologies’ adaptive sampling and the Twist long-read PGx panel for pharmacogenomic profiling

in Pharmacogenetics and Pharmacogenomics

Koen Deserranno
Laurentijn Tilleman
Dieter Deforce
Filip Van Nieuwerburgh

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1653999

3,994 views
2 citations

Original Research

Published on 26 Jan 2023

PAnno: A pharmacogenomics annotation tool for clinical genomic testing

in Pharmacogenetics and Pharmacogenomics

Yaqing Liu
Zipeng Lin
Qingwang Chen
Qiaochu Chen
Leqing Sang
Yunjin Wang
Leming Shi
Li Guo
Ying Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1008330

9,888 views
10 citations

Brief Research Report

Published on 28 Nov 2023

Personalized medicine in a community health system: the NorthShore experience

in Pharmacogenetics and Pharmacogenomics

Sean P. David
Henry M. Dunnenberger
Sarah Choi
Allison DePersia
Nadim Ilbawi
Christopher Ward
Dyson T. Wake
Janardan D. Khandekar
Yvette Shannon
Kristen Hughes

Frontiers in Genetics

doi 10.3389/fgene.2023.1308738

6,958 views
19 citations

Editorial

Published on 11 Jan 2022

Editorial: Pharmacogenetics and Pharmacogenomics in Latin America: Ethnic Variability, New Insights in Advances and Perspectives: A RELIVAF-CYTED Initiative

in Pharmacogenetics and Pharmacogenomics

Patricia Esperón
Matías F. Martínez
María A. Redal
Alberto Lazarowski
Andrés López-Cortés
Nelson M. Varela
Luis A. Quiñones

Frontiers in Pharmacology

doi 10.3389/fphar.2021.833000

2,978 views
5 citations

Editorial

Published on 03 May 2023

Editorial: Pharmacogenetics and pharmacogenomics in Latin America: ethnic variability, new insights in advances and perspectives: a RELIVAF-CYTED initiative, Volume II

in Pharmacogenetics and Pharmacogenomics

Andrés López-Cortés
Patricia Esperón
Matías F. Martínez
María A. Redal
Alberto Lazarowski
Nelson M. Varela
Ismael Lares-Asseff
Luis A. Quiñones

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1211712

2,472 views
4 citations

Brief Research Report

Published on 12 Apr 2022

Sub-Analysis of CYP-GUIDES Data: Assessing the Prevalence and Impact of Drug-Gene Interactions in an Ethnically Diverse Cohort of Depressed Individuals

in Drugs Outcomes Research and Policies

Rustin D. Crutchley
Nicole Keuler

Frontiers in Pharmacology

doi 10.3389/fphar.2022.884213

2,616 views
6 citations

Original Research

Published on 15 Nov 2022

Pharmacogenomics driven decision support prototype with machine learning: A framework for improving patient care

in Medicine and Public Health

Farah Kidwai-Khan
Christopher T. Rentsch
Rebecca Pulk
Charles Alcorn
Cynthia A. Brandt
Amy C. Justice

Frontiers in Big Data

doi 10.3389/fdata.2022.1059088

4,289 views
11 citations

Original Research

Published on 13 Jun 2023

Data mining identifies novel RNA-binding proteins involved in colon and rectal carcinomas

in Cancer Cell Biology

Jennyfer M. García-Cárdenas
Isaac Armendáriz-Castillo
Nathali García-Cárdenas
David Pesantez-Coronel
Andrés López-Cortés
Alberto Indacochea
Santiago Guerrero

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1088057

5,739 views
9 citations

Original Research

Published on 29 Mar 2022

Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials

in Pharmacology of Infectious Diseases

Andrés López-Cortés
Santiago Guerrero
Esteban Ortiz-Prado
Verónica Yumiceba
Antonella Vera-Guapi
Ángela León Cáceres
Katherine Simbaña-Rivera
Ana María Gómez-Jaramillo
Gabriela Echeverría-Garcés
Jennyfer M. García-Cárdenas

Frontiers in Pharmacology

doi 10.3389/fphar.2022.833174

7,988 views
12 citations

Original Research

Published on 12 Apr 2021

A New Insight for the Identification of Oncogenic Variants in Breast and Prostate Cancers in Diverse Human Populations, With a Focus on Latinos

in Pharmacogenetics and Pharmacogenomics

Nelson M. Varela
Patricia Guevara-Ramírez
Cristian Acevedo
Tomás Zambrano
Isaac Armendáriz-Castillo
Santiago Guerrero
Luis A. Quiñones
Andrés López-Cortés

Frontiers in Pharmacology

doi 10.3389/fphar.2021.630658

5,617 views
8 citations

Original Research

Published on 02 May 2024

Gastric cancer actionable genomic alterations across diverse populations worldwide and pharmacogenomics strategies based on precision oncology

in Pharmacogenetics and Pharmacogenomics

Gabriela Echeverría-Garcés
María José Ramos-Medina
Rodrigo Vargas
Alejandro Cabrera-Andrade
Adriana Altamirano-Colina
María Paula Freire
Juliana Montalvo-Guerrero
Sebastián Rivera-Orellana
Paulina Echeverría-Espinoza
Luis A. Quiñones

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1373007

5,902 views
7 citations

Editorial

Published on 01 Dec 2022

Editorial: Rising stars in virus and host: 2022

in Virus and Host

Andres López-Cortés
Santiago Guerrero

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2022.1100695

2,719 views

Original Research

Published on 19 May 2021

Pharmacogenetic Associations Between Atazanavir/UGT1A1*28 and Efavirenz/rs3745274 (CYP2B6) Account for Specific Adverse Reactions in Chilean Patients Undergoing Antiretroviral Therapy

in Pharmacogenetics and Pharmacogenomics

Daniela Poblete
Fernando Bernal
Gabriel Llull
Sebastian Archiles
Patricia Vasquez
Leonardo Chanqueo
Nicole Soto
María A. Lavanderos
Luis A. Quiñones
Nelson M. Varela

Frontiers in Pharmacology

doi 10.3389/fphar.2021.660965

5,972 views
6 citations

Articles

Integrating Next-Generation Sequencing in the Clinical Pharmacogenomics Workflow

Assessing user perspectives on clinical pharmacogenomics consultation documentation: a user-centered evaluation

Pharmacogenetic Factors Affecting Asthma Treatment Response. Potential Implications for Drug Therapy

Comparative evaluation of Oxford Nanopore Technologies’ adaptive sampling and the Twist long-read PGx panel for pharmacogenomic profiling

PAnno: A pharmacogenomics annotation tool for clinical genomic testing

Personalized medicine in a community health system: the NorthShore experience

Editorial: Pharmacogenetics and Pharmacogenomics in Latin America: Ethnic Variability, New Insights in Advances and Perspectives: A RELIVAF-CYTED Initiative

Editorial: Pharmacogenetics and pharmacogenomics in Latin America: ethnic variability, new insights in advances and perspectives: a RELIVAF-CYTED initiative, Volume II

Sub-Analysis of CYP-GUIDES Data: Assessing the Prevalence and Impact of Drug-Gene Interactions in an Ethnically Diverse Cohort of Depressed Individuals

Pharmacogenomics driven decision support prototype with machine learning: A framework for improving patient care

Data mining identifies novel RNA-binding proteins involved in colon and rectal carcinomas

Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials

A New Insight for the Identification of Oncogenic Variants in Breast and Prostate Cancers in Diverse Human Populations, With a Focus on Latinos

Gastric cancer actionable genomic alterations across diverse populations worldwide and pharmacogenomics strategies based on precision oncology

Editorial: Rising stars in virus and host: 2022

Pharmacogenetic Associations Between Atazanavir/UGT1A1*28 and Efavirenz/rs3745274 (CYP2B6) Account for Specific Adverse Reactions in Chilean Patients Undergoing Antiretroviral Therapy